Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation

International Journal of Public Health

Volumn 60, Issue 5, 2015, Pages 561-572

  Ghayour Mobarhan, Majid ^a,b   Moohebati, Mohsen ^a,b   Esmaily, Habibollah ^a,c   Ebrahimi, Mahmoud ^b   Parizadeh, Seyed Mohammad Reza ^a   Heidari Bakavoli, Ali Reza ^b   Safarian, Mohammad ^a   Mokhber, Naghmeh ^d   Nematy, Mohsen ^a   Saber, Hamidreza ^e   Mohammadi, Maryam ^a   Andalibi, Mohammad Sobhan Sheikh ^a   Ferns, Gordon A ^f   Azarpazhooh, Mahmoud Reza ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Cardiovascular disease; Epidemiology; Iran; Metabolic syndrome; Risk factor

Indexed keywords

GLUCOSE BLOOD LEVEL; LIPID;

ADULT; ANXIETY; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; INCIDENCE; IRAN; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; MORPHOMETRICS; MULTICENTER STUDY; PREVALENCE; RISK FACTOR; SOCIOECONOMICS; STROKE;

ADULT; ANXIETY; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHTS AND MEASURES; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH BEHAVIOR; HUMANS; INCIDENCE; IRAN; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; RESEARCH DESIGN; RISK FACTORS; SOCIOECONOMIC FACTORS; STROKE;

EID: 84933182607     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-015-0679-6     Document Type: Article

References (32)

1. Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M, Ghandehary K, Farzadfard MT, Kiani R, Panahandeh M, Thrift AG (2010) Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke 41:e3–e10
2. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi Y, Saadat N, Salehi P, Mortazavi N, Heydarian P, Sarbazi N, Allahverdian S, Saadati N, Ainy E, Moeini S (2002) Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 47:408–426
3. Beaglehole R (1993) Cardiovascular disease in developing countries. BMJ 306:395
4. Beaglehole R, Stewart AW, Jackson R, Dobson AJ, McElduff P, D’Este K, Heller RF, Jamrozik KD, Hobbs MS, Parsons R, Broadhurst R (1997) Declining rates of coronary heart disease in New Zealand and Australia, 1983–1993. Am J Epidemiol 145:707–713
5. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 256:2835–2838
6. Dawber TR, Moore FE, Mann GV (1957) Coronary heart disease in the Framingham study. Am J Public Health Nations Health 47:4–24
7. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 32:1092–1097
8. Ergör G, Soysal A, Sözmen K, Ünal B, Uçku R, Kılıç B, Günay T, Ergör A, Demiral Y, Saatlı G, Meseri R, Baydur H, Simşek H, Budak R, Arık H, Karakuş N (2012) Balcova heart study: rationale and methodology of the Turkish cohort. Int J Public Health 57:535–542
9. Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, Forouzanfar M, Hodjatzadeh A, Ramezani RD (2008) Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens 21:620–626
10. Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM (2006) Changes in incidence of diabetes in US adults, 1997–2003. Am J Prev Med 30:371–377
11. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F (2010) Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis 9:85
12. Hajian-Tilaki KO, Heidari B (2007) Prevalence of obesity, central obesity and the associated factors in urban population aged 20–70 years, in the north of Iran: a population-based study and regression approach. Obes Rev 8:3–10
13. Harati H, Hadaegh F, Saadat N, Azizi F (2009) Population-based incidence of Type 2 diabetes and its associated risk factors: results from a 6-year cohort study in Iran. BMC Public Health 9:186
14. Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54:541–553
15. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335:136
16. Husten L (1998) Global epidemic of cardiovascular disease predicted. Lancet 352:1530
17. Kelishadi R, Alikhani S, Delavari A, Alaedini F, Safaie A, Hojatzadeh E (2008) Obesity and associated lifestyle behaviours in Iran: findings from the First National Non-communicable Disease Risk Factor Surveillance Survey. Public Health Nutr 11:246–251
18. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355:675–687
19. Lloyd BL (1994) Declining cardiovascular disease incidence and environmental components. Aust N Z J Med 24:124–132
20. Luepker RV, Murray DM, Jacobs DR Jr, Mittelmark MB, Bracht N, Carlaw R, Crow R, Elmer P, Finnegan J, Folsom AR (1994) Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health 84:1383–1393
21. Masoudkabir F, Toghianifar N, Talaie M, Sadeghi M, Sarrafzadegan N, Mohammadifard N, Marshall T, Thomas GN (2012) Socioeconomic status and incident cardiovascular disease in a developing country: findings from the Isfahan cohort study (ICS). Int J Public Health 57:561–568
22. Monge R, Beita O (2000) Prevalence of coronary heart disease risk factors in Costa Rican adolescents. J Adolesc Health 27:210–217
23. Najeeb MA (1993) Cardiovascular disease in developing countries. BMJ 306:927
24. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ (1998) Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280:2001–2007
25. Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, Sajjadieh AR, Kabiri P, Marshall T, Thomas GN, Tavasoli A (2010) The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens 25:545–553
26. Sarraf-Zadegan N, Boshtam M, Malekafzali H, Bashardoost N, Sayed-Tabatabaei FA, Rafiei M, Khalili A, Mostafavi S, Khami M, Hassanvand R (1999) Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan. Acta Cardiol 54:327–333
27. Schweigman K, Eichner J, Welty TK, Zhang Y (2006) Cardiovascular disease risk factor awareness in American Indian communities: the strong heart study. Ethn Dis 16:647–652
28. Slavenka J, Dragana S, Janko J, Miloš E, Jelena M (2014) Status of cardiovascular health in a transition European country: findings from a population-based cross-sectional study. Int J Public Health. 59:769–778
29. Smith EN, Chen W, Kahonen M, Kettunen J, Lehtimaki T, Peltonen L, Raitakari OT, Salem RM, Schork NJ, Shaw M, Srinivasan SR, Topol EJ, Viikari JS, Berenson GS, Murray SS (2010) Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study. PLoS Genet 6:e1001094
30. Sytkowski PA, D’Agostino RB, Belanger A, Kannel WB (1996) Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950–1989. Am J Epidemiol 143:338–350
31. Uthoff H, Staub D, Socrates T, Meyerhans A, Bundi B, Schmid HP, Frauchiger B (2010) PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis. Vasa 39:325–333
32. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB (1980) Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 46:649–654